Changes in adipose tissue depots and metabolic markers following a 1-year diet and exercise intervention in overweight and obese patients with type 2 diabetes

Diabetes Care

Volumn 37, Issue 12, 2014, Pages 3325-3332

  Gallagher, Dympna ^a,b   Heshka, Stanley ^a,b   Kelley, David E ^c,d   Thornton, John ^a   Boxt, Lawrence ^a   Pi Sunyer, F Xavier ^a   Patricio, Jennifer ^a   Mancino, Juliet ^c   Clark, Jeanne M ^e   Janumala, Isaiah ^f   Davidson, Lance ^f  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADIPOSE TISSUE; ADULT; AGED; ARM; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE INTENSITY; FEMALE; HUMAN; INTERMUSCULAR ADIPOSE TISSUE; INTRAABDOMINAL FAT; KINESIOTHERAPY; LEG; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SUBCUTANEOUS FAT; THERAPY EFFECT; TREATMENT DURATION; TRUNK; WEIGHT CHANGE; WEIGHT REDUCTION; BEHAVIOR THERAPY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIET THERAPY; EXERCISE; LIFESTYLE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; WEIGHT LOSS PROGRAM;

ADIPOSE TISSUE; ADIPOSITY; AGED; BEHAVIOR THERAPY; BIOMARKERS; DIABETES MELLITUS, TYPE 2; DIET THERAPY; EXERCISE; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84911944727     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-1585     Document Type: Article

References (41)

1. Gallagher D, Kelley DE, Yim JE, et al.; MRI Ancillary Study Group of the Look AHEAD Research Group. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009;89:807-814
2. Goodpaster BH, Thaete FL, Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 2000;71:885-892
3. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005;165:777-783
4. Azuma K, Heilbronn LK, Albu JB, Smith SR, Ravussin E, Kelley DE; Look AHEAD Adipose Research Group. Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2007;293:E435-E442
5. Eastwood SV, Tillin T, Wright A, et al. Thigh fat and muscle each contribute to excess cardiometabolic risk in South Asians, independent of visceral adipose tissue. Obesity (Silver Spring) 2014;22:2071-2079
6. Gallagher D, Kovera AJ, Clay-Williams G, et al. Weight loss in postmenopausal obesity: no adverse alterations in body composition and protein metabolism.Am J Physiol Endocrinol Metab 2000;279:E124-E131
7. Lee S, Kuk JL, Davidson LE, et al. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes. J Appl Physiol (1985) 2005;99:1220-1225
8. Davidson LE, Hudson R, Kilpatrick K, et al. Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial. Arch Intern Med 2009;169:122-131
9. Pi-Sunyer X, Blackburn G, Brancati FL, et al.; Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007;30:1374-1383
10. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes 1997;46:456-462
11. Ryan AS, Nicklas BJ. Age-related changes in fat deposition in mid-thigh muscle in women: relationships with metabolic cardiovascular disease risk factors. Int J Obes Relat Metab Disord 1999;23:126-132
12. Goodpaster BH, Krishnaswami S, Resnick H, et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003;26:372-379
13. Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM. Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab 2005;90:4573-4578
14. Snijder MB, Dekker JM, Visser M, et al.; Hoorn study. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care 2004;27:372-377
15. Ryan DH, Espeland MA, Foster GD, et al.; Look AHEAD Research Group. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003;24:610-628
16. Wadden TA, West DS, Delahanty L, et al.; Look AHEAD Research Group. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it [published correction appears in Obesity (Silver Spring) 2007;15:1339]. Obesity (Silver Spring) 2006;14:737-752
17. Jakicic JM, Jaramillo SA, Balasubramanyam A, et al.; Look AHEAD Study Group. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Int J Obes (Lond) 2009;33:305-316
18. Albu JB, Heilbronn LK, Kelley DE, et al.; Look AHEAD Adipose Research Group. Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes 2010;59:627-633
19. Song MY, Ruts E, Kim J, Janumala I, Heymsfield S, Gallagher D. Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr 2004;79:874-880
20. Snyder WS, Cooke MJ, Mnassett ES, Larhansen LT, Howells GP, Tipton IH. Report of the Task Group on Reference Man. Oxford, Pergamon, 1975
21. Hallgreen CE, Hall KD. Allometric relationship between changes of visceral fat and total fat mass. Int J Obes (Lond) 2008;32:845-852
22. de Souza RJ, Bray GA, Carey VJ, et al. Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr 2012;95:614-625
23. Albu JB, Kovera AJ, Allen L, et al. Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women. Am J Clin Nutr 2005;82:1210-1217
24. Yim JE, Heshka S, Albu J, et al. Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. Int J Obes (Lond) 2007;31:1400-1405
25. Doucet E, St-Pierre S, Alméras N, et al. Reduction of visceral adipose tissue during weight loss. Eur J Clin Nutr 2002;56:297-304
26. Gasteyger C, Larsen TM, Vercruysse F, Pedersen D, Toubro S, Astrup A. Visceral fat loss induced by a low-calorie diet: a direct comparison between women and men. Diabetes Obes Metab 2009;11:596-602
27. Janssen I, Ross R. Effects of sex on the change in visceral, subcutaneous adipose tissue and skeletal muscle in response to weight loss. Int J Obes Relat Metab Disord 1999;23:1035-1046
28. Chaston TB, Dixon JB. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes (Lond) 2008;32:619-628
29. Chaston TB, Dixon JB, O'Brien PE. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond) 2007;31:743-750
30. Smith SR, Zachwieja JJ. Visceral adipose tissue: a critical review of intervention strategies. Int J Obes Relat Metab Disord 1999;23:329-335
31. Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes 2011;2011:490650
32. Yang YK, Chen M, Clements RH, Abrams GA, Aprahamian CJ, Harmon CM. Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes. Cell Physiol Biochem 2008;22:531-538
33. Virtanen KA, Lönnroth P, Parkkola R, et al. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab 2002;87:3902-3910
34. Snijder MB, Visser M, Dekker JM, et al.; Health ABC Study. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005;48:301-308
35. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48
36. Rhéaume C, Arsenault BJ, Bélanger S, et al. Low cardiorespiratory fitness levels and elevated blood pressure: what is the contribution of visceral adiposity? Hypertension 2009;54:91-97
37. Therkelsen KE, Pedley A, Speliotes EK, et al. Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2013;33:863-870
38. Gabriely I, Ma XH, Yang XM, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002;51:2951-2958
39. Fabbrini E, Tamboli RA, Magkos F, et al. Surgical removal ofomental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 2010;139:448-455
40. Dillard TH, Purnell JQ, Smith MD, et al. Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial. Surg Obes Relat Dis 2013;9:269-275
41. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004;350:2549-2557